Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 4/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.33 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.31 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL2831718 | 0.97 | CYP3A4 (0.41) | CYP3A4TDP1ESR1ESR2 | |
| Iodide SCHEMBL2831739 | 0.97 | CYP3A4 (0.41) | CYP3A4TDP1ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL6327 | 0.97 | CYP3A4 (0.41) | CYP3A4TDP1ESR1ESR2KDM4E | |
| SCHEMBL35092 | 0.97 | CYP3A4 (0.45) | CYP3A4TDP1ESR1ESR2KCNA3 | |
| SCHEMBL954340 | 0.94 | CYP3A4 (0.43) | CYP3A4TDP1ESR1ESR2KCNA3 | |
| SCHEMBL4255002 | 0.94 | CYP3A4 (0.43) | CYP3A4TDP1ESR1ESR2KCNA3 | |
| SCHEMBL31379074 | 0.94 | CYP3A4 (0.43) | CYP3A4TDP1ESR1ESR2KCNA3 | |
| SCHEMBL22749145 | 0.94 | CYP3A4 (0.43) | CYP3A4TDP1ESR1ESR2KCNA3 | |
| SCHEMBL22749132 | 0.94 | CYP3A4 (0.43) | CYP3A4TDP1ESR1ESR2KCNA3 | |
| SCHEMBL7934432 | 0.94 | CYP3A4 (0.43) | CYP3A4TDP1ESR1ESR2KCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119421876-A | Compounds and medicaments as DDR1 kinase inhibitors | 日本新药株式会社 | 2025-02-11 | — | — | CN | disclosed |
| CN-119371371-A | Compounds and compositions as PDGF receptor kinase inhibitors | 日本新药株式会社 | 2025-01-28 | — | — | CN | disclosed |
| CN-115315421-B | Compounds and compositions as PDGF receptor kinase inhibitors | 日本新药株式会社 | 2024-12-03 | — | — | CN | disclosed |
| CN-117769546-A | Allosteric ketene inhibitors of phosphoinositide 3-kinase (PI 3K) for the treatment of disease | 佩特拉制药公司 | 2024-03-26 | — | — | CN | disclosed |